Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / STRM.BIO

STRM.BIO

SeedUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$8.0Msum of rounds with a disclosed amount only
Named investors
5
Financing history
1 rounds
  1. Jan 7, 2026
    Seed · $8.0M (disclosed)
    Blue Bay Capital New Investment (participant)Boehringer Ingelheim Ventures (participant)Delos Capital (participant)Delos (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy”
Investors on record
5 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Jan 7, 2026
    STRM.BIO announced Seed of $8,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
2 observations
Every observation on this company